CalciMedica, Inc. SEC filings CALC
CalciMedica, Inc. has 531 filings in SEC EDGAR's recent list, going back to Nov 8, 2011. Its latest annual report, Form ARS, was filed on Jul 23, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 11, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 16, 2026 (officer or director change). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| 8-K |
Current report
Officer or director change
|
Oct 16, 2026 | Oct 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 30, 2026 | Sep 30, 2026 |
| 8-K |
Current report
Other events
|
Sep 16, 2026 | Sep 15, 2026 |
| 8-K |
Current report
Other events
|
Sep 2, 2026 | Aug 31, 2026 |
| 8-K |
Current report
Bylaw or fiscal year change
|
Aug 27, 2026 | Aug 27, 2026 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 20, 2026 | Aug 19, 2026 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2026 | Aug 11, 2026 |
| 8-K |
Current report
Officer or director change
|
Jul 7, 2026 | Jul 2, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale, Regulation FD disclosure, Other events
|
Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Material agreement, Unregistered share sale
|
Jun 24, 2026 | Jun 23, 2026 |
| 8-K |
Current report
Results of operations
|
May 12, 2026 | May 12, 2026 |
| 8-K |
Current report
Listing notice
|
Mar 18, 2026 | Mar 13, 2026 |
| 8-K |
Current report
Results of operations
|
Mar 3, 2026 | Mar 2, 2026 |
| 8-K |
Current report
Other events
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jan 28, 2026 | Jan 28, 2026 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2025 | Nov 12, 2025 |
| 8-K |
Current report
Other events
|
Nov 6, 2025 | Nov 6, 2025 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2025 | Aug 12, 2025 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Jun 27, 2025 | Jun 24, 2025 |
| 8-K |
Current report
Auditor change
|
Jun 6, 2025 | Jun 3, 2025 |
| 8-K |
Current report
Results of operations
|
May 14, 2025 | May 14, 2025 |
| 8-K |
Current report
Results of operations
|
Mar 27, 2025 | Mar 27, 2025 |
| 8-K |
Current report
Material agreement, New debt, Unregistered share sale, Other events
|
Mar 5, 2025 | Feb 28, 2025 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Mar 4, 2025 | Mar 4, 2025 |
| 8-K |
Current report
Officer or director change
|
Jan 14, 2025 | Jan 10, 2025 |
| 8-K |
Current report
Other events
|
Dec 20, 2024 | Dec 20, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 13, 2024 | Nov 13, 2024 |
| 8-K |
Current report
Officer or director change
|
Nov 8, 2024 | Nov 6, 2024 |
| 8-K |
Current report
Material agreement, Other events
|
Oct 31, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Results of operations, Other events
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Oct 30, 2024 | Oct 30, 2024 |
| 8-K |
Current report
Officer or director change, Shareholder vote results
|
Aug 27, 2024 | Aug 27, 2024 |
| 8-K |
Current report
Results of operations
|
Aug 12, 2024 | Aug 12, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Jun 27, 2024 | Jun 27, 2024 |
| 8-K |
Current report
Results of operations
|
May 13, 2024 | May 13, 2024 |
| 8-K |
Current report
Auditor change
|
Apr 10, 2024 | Apr 5, 2024 |
| 8-K |
Current report
Other events
|
Mar 29, 2024 | Mar 29, 2024 |
| 8-K |
Current report
Results of operations
|
Mar 28, 2024 | Mar 28, 2024 |
| 8-K |
Current report
Regulation FD disclosure, Other events
|
Feb 13, 2024 | Feb 13, 2024 |
| 8-K/A |
Amended current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 24, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Material agreement, Results of operations, Unregistered share sale, Regulation FD disclosure, Other events
|
Jan 22, 2024 | Jan 19, 2024 |
| 8-K |
Current report
Results of operations
|
Nov 9, 2023 | Nov 9, 2023 |
| 8-K |
Current report
Results of operations, Other events
|
Nov 2, 2023 | Nov 2, 2023 |
| 8-K |
Current report
Other events
|
Aug 11, 2023 | Aug 11, 2023 |
| 8-K |
Current report
Results of operations, Shareholder vote results
|
Aug 10, 2023 | Aug 9, 2023 |
| 8-K | Current report | Jun 27, 2023 | Jun 23, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 15, 2023 | Jun 14, 2023 |
| 8-K |
Current report
Regulation FD disclosure
|
Jun 12, 2023 | Jun 12, 2023 |
| 8-K |
Current report
Results of operations
|
May 15, 2023 | May 15, 2023 |
| 8-K/A | Amended current report | May 12, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Restatement
|
May 12, 2023 | May 8, 2023 |
| 8-K |
Current report
Listing notice, Other events
|
May 5, 2023 | Apr 26, 2023 |
| 8-K/A | Amended current report | Apr 4, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Acquisition or sale of assets, Listing notice, Unregistered share sale, Change to shareholder rights, Change in control, Officer or director change, Bylaw or fiscal year change, Other events
|
Mar 22, 2023 | Mar 17, 2023 |
| 8-K |
Current report
Shareholder vote results, Other events
|
Mar 15, 2023 | Mar 15, 2023 |
| 8-K |
Current report
Officer or director change, Other events
|
Mar 3, 2023 | Feb 28, 2023 |
| 8-K |
Current report
Material agreement
|
Feb 16, 2023 | Feb 10, 2023 |
| 8-K |
Current report
Officer or director change
|
Feb 9, 2023 | Feb 5, 2023 |
| 8-K |
Current report
Listing notice
|
Dec 28, 2022 | Dec 27, 2022 |
| 8-K |
Current report
Other events
|
Nov 22, 2022 | Nov 21, 2022 |
| 8-K |
Current report
Material agreement, Other events
|
Nov 22, 2022 | Nov 21, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 10, 2022 | Nov 10, 2022 |
| 8-K |
Current report
Exit or restructuring costs, Impairment
|
Aug 23, 2022 | Aug 18, 2022 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2022 | Aug 11, 2022 |
| 8-K |
Current report
Listing notice
|
Jun 21, 2022 | Jun 16, 2022 |
| 8-K |
Current report
Shareholder vote results
|
Jun 3, 2022 | Jun 2, 2022 |
| 8-K |
Current report
Results of operations
|
May 10, 2022 | May 10, 2022 |
| 8-K |
Current report
Officer or director change, Regulation FD disclosure
|
Apr 18, 2022 | Apr 13, 2022 |
| 8-K |
Current report
Results of operations
|
Mar 10, 2022 | Mar 10, 2022 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2021 | Nov 11, 2021 |
| 8-K |
Current report
Results of operations
|
Aug 11, 2021 | Aug 11, 2021 |
| 8-K |
Current report
Shareholder vote results
|
Jun 4, 2021 | Jun 4, 2021 |
| 8-K |
Current report
Results of operations
|
May 12, 2021 | May 12, 2021 |
| 8-K |
Current report
Results of operations
|
Mar 5, 2021 | Mar 5, 2021 |
| 8-K |
Current report
Results of operations
|
Nov 12, 2020 | Nov 12, 2020 |
Showing 75 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- CALC (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- La Jolla, CA
- SEC filer status
- Non-accelerated filer, Smaller reporting company
- SEC CIK
- 1534133
- Former names
- CalciMedica, Inc. /DE/ (until Mar 22, 2023); GRAYBUG VISION, INC. (until Mar 15, 2023); GRAYBUG, Inc. (until May 13, 2016); GRAYBUG LLC (until Oct 7, 2014)
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.